Pfizer weighing a $2B women's health sale, report says. Will it fare better than Allergan?

1st November 2018 Uncategorised 0

Earlier this year, Pfizer struck out on a sale of its consumer health unit. But now it may be ready to try its hand at another selloff. The New York drugmaker is weighing options for its women’s health lineup, Bloomberg reported Thursday, in what could be a $2 billion deal.

More: Pfizer weighing a B women's health sale, report says. Will it fare better than Allergan?
Source: fierce